Key result
Advanced therapies for deep venous thrombosis and pulmonary embolism provide unique techniques to ameliorate the clinical course when anticoagulation alone is insufficient.
This article reviews advanced therapies for deep venous thrombosis and pulmonary embolism when standard anticoagulation is insufficient.
Answers are grounded in this paper and cite their sources.
No practice change from this review alone; leaves open optimal selection of advanced therapies for refractory DVT/PE.
Advanced therapies are available for both deep venous thrombosis and pulmonary embolism when anticoagulation alone is not sufficient to improve clinical outcomes. In some cases, clinical deterioration ensues despite anticoagulation, and this requires unique techniques that can ameliorate the clinical course. Such advancements are described in this upcoming article.
No takes yet. Share an insight, caveat, or question.
Yadam et al. (2017) studied this question. Advanced therapies for deep venous thrombosis and pulmonary embolism provide unique techniques to ameliorate the clinical course when anticoagulation alone is insufficient.
Synapse has enriched 10 related papers. Consider them for comparative context: